The BPH/5 Mouse Model of Superimposed Preeclampsia Is Not a Model of HELLP Syndrome.
The BPH/5 Mouse Model of Superimposed Preeclampsia Is Not a Model of HELLP Syndrome.
复制标题
DOI:
10.3390/biology10111179
复制
发表时间:
2021-11-14
期刊:
影响因子:
4.2
通讯作者:
Sones JL
中科院分区:
文献类型:
--
作者:
Johnston AN;Batts TL;Langohr IM;Moeller C;Liu CC;Sones JL
HELLP syndrome ((H) for hemolysis, (EL) for elevated liver transaminases, and (LP) for low platelets) occurs in up to 20% of women with severe preeclampsia. Disrupted placental development is causal to both preeclampsia and HELLP syndrome, yet why HELLP syndrome develops in some women remains unclear. Targeted treatments for this devastating disease are currently unavailable, and the development of preclinical models is imperative. Therefore, we sought to determine whether the blood pressure high subline 5 (BPH/5) mouse, a spontaneous model of preeclampsia, could also serve as a model of HELLP syndrome. Although anemia, thrombocytopenia, and plasma markers of liver dysfunction were not found in the BPH/5 mouse during pregnancy, precluding it as a model of PE associated with HELLP syndrome, a progressive fatty liver phenotype was identified. The BPH/5 mouse may be useful as a model of hepatic steatosis in superimposed preeclampsia. Preeclampsia (PE) is a multisystemic disease of pregnancy affecting 2–8% of women worldwide. PE-induced liver disease is a rare but important complication of pregnancy. The pathogenesis of liver dysfunction in PE is poorly understood, but is correlated with dysregulated angiogenic, inflammatory, and hypoxic events in the early phase of placental development. Because BPH/5 mice develop the maternal and fetal hallmarks of PE during pregnancy, we hypothesized that they may also share the clinicopathologic findings of the human PE-associated hemolysis elevated liver transaminases low platelets (HELLP) syndrome. Using this model, we determined that microangiopathic hemolysis, thrombocytopenia, and elevated liver enzymes do not occur in mid to late gestation. Pregnant BPH/5 mice do not develop histologic evidence of hepatic inflammation, but they do have increased microsteatosis scores at preconception and in mid to late gestation that progress to macrosteatosis in a subset of mice in late gestation. The transcriptional upregulation of TNF-α, CXCL-10, and TLR-2 occurs in mid gestation prior to the onset of macrosteatosis. The BPH/5 female mouse is not a model of HELLP syndrome, but may be a model of fatty liver disease associated with pregnancy.
登录
查看更多内容
影响因子:
4.6
作者:
Reijnders, Dorien;Liu, Chin-Chi;Sones, Jenny L.
通讯作者:
Sones, Jenny L.
影响因子:
4.6
作者:
Oe Y;Ko M;Fushima T;Sato E;Karumanchi SA;Sato H;Sugawara J;Ito S;Takahashi N
通讯作者:
Takahashi N
影响因子:
8.3
作者:
Davisson, RL;Hoffmann, DS;Bates, JN
通讯作者:
Bates, JN
影响因子:
3.7
作者:
Liang W;Menke AL;Driessen A;Koek GH;Lindeman JH;Stoop R;Havekes LM;Kleemann R;van den Hoek AM
通讯作者:
van den Hoek AM
DOI:
10.1152/ajpregu.00334.2018
发表时间:
2019-07-01
影响因子:
2.8
作者:
Reijnders, Dorien;Olson, Kelsey N.;Sones, Jenny L.
通讯作者:
Sones, Jenny L.